AKTS
Aktis Oncology, Inc.
19.40$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -534.4% | |
| – | +30.2% | +776.7% | +1,046.9% | +97.8% | +27.7% | +154.8% | -94.5% | +151.7% | +40.6% | +47.9% | |
| – | +87.9% | +796.6% | +40.6% | +31.9% | -7.0% | +52.2% | -93.2% | +111.7% | +52.9% | +127.0% | |
| – | +6,114.8% | +260.1% | +89.0% | -123.4% | – | -579.2% | – | – | – | -105.5% | |
| – | -57.7% | +3,470.4% | +316.1% | -29.8% | +102.1% | +178.6% | -91.7% | +63.2% | -24.0% | +234.9% | |
| – | -57.7% | +9,498.3% | +54.8% | -30.3% | +102.2% | +253.3% | -93.4% | +2,883.4% | +176.6% | – | |
| – | -47.8% | +504.6% | +69.7% | +43.5% | +19.9% | +59.1% | +66.0% | -72.8% | +462.5% | -100.7% | |
| – | -62.9% | +284.2% | -5.3% | +195.8% | -7.1% | -155.0% | – | -199.3% | – | -91.8% | |
| – | – | – | – | – | – | – | – | – | – | -719.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.